Oxford-AstraZeneca has been pressured to defend its Covid-19 vaccine after a number of European nations together with Norway, Denmark, Iceland, Bulgaria and even Asian nation Thailand paused the roll out of the vaccine following stories it may very well be related to blood clots.
Bulgaria joined Denmark, Norway and Iceland to droop the usage of the vaccine pending investigations into security.
Bulgarian Prime Minister Boyko Borissov ordered a halt to all inoculation till the European Medicines Company “rejects all doubts” in regards to the vaccine’s security, based on a authorities assertion.
The transfer got here in response to stories of blood clots in a couple of inoculated folks in Denmark, together with one fatality.
Thailand’s Prime Minister, Prayut Chan-o-cha, canceled plans to publicly get the AstraZeneca shot this weekend and the nation additionally delayed its rollout.
“When there may be an hostile occasion, we do not should be in rush,” mentioned Piyasakol Sakolsatayadorn, a senior member of the nation’s vaccination committee.
AstraZeneca has responded. In a press release the vaccine maker mentioned there may be “no proof of an elevated threat” of blood clots, and European and UK medicines regulators have every mentioned the hyperlink between the vaccine and blood clots has not been confirmed and that rollouts ought to proceed.
The Norwegian Institute of Public Well being mentioned the nation has additionally reported instances of blood clots shortly after receiving a Covid-19 vaccination in Norway however “primarily within the aged the place there may be usually one other underlying illness as nicely.”
Different international locations, together with Austria and Italy, have suspended particular batches of the vaccine.
The European Medicines Company (EMA) has mentioned that it didn’t suggest suspending use of the AstraZeneca vaccine, stating that there’s “no indication” the vaccine triggered the blood clots within the individuals who acquired the vaccine. The company advised international locations they may preserve rolling out the shot whereas investigations happen.
“The vaccine’s advantages proceed to outweigh its dangers and the vaccine can proceed to be administered whereas investigation of instances of thromboembolic occasions is ongoing,” the company mentioned.
Well being companies of the UK, Germany, France, the Netherlands, Mexico and Nigeria are nonetheless administering the vaccine, saying it is protected.